(Press-News.org) nderstanding exactly how psychedelics promote new connections in the brain is critical to developing targeted, non-hallucinogenic therapeutics that can treat neurodegenerative and neuropsychiatric diseases. To achieve this, researchers are mapping the biochemical pathways involved in both neuroplasticity and hallucinations.
In new research led by the University of California, Davis, researchers found that non-hallucinogenic versions of psychedelic drugs promote neuroplasticity through the same biochemical pathway as psychedelics. However, unlike psychedelics, they don’t activate genes long thought to be key players in that process.
The research, published Aug. 4 in Nature Neuroscience, compared the biochemical pathways activated by the hallucinogenic compound 5-MeO-DMT and its non-hallucinogenic analog tabernanthalog (TBG).
“The prevailing hypothesis in the field was that psychedelics promote neuroplasticity by causing this big burst of glutamate in the brain, which then turns on intermediate early genes,” said David E. Olson, director of the Institute for Psychedelics and Neurotherapeutics and a professor of chemistry and of biochemistry and molecular medicine at UC Davis. “We now know that non-hallucinogenic compounds like TBG can promote neuroplasticity without inducing a glutamate burst or immediate early gene activation.”
“This work challenges the current dogma in the field,” said John A. Gray, a co-author of the study and the associate director of the Institute for Psychedelics and Neurotherapeutics as well as a professor in the Center for Neuroscience at UC Davis.
The team found that TBG promotes neuroplasticity by activating the same psychedelic receptor as 5-MeO-DMT, but the difference is the extent of the activation.
The researchers also provide the first direct evidence that a non-hallucinogenic psychedelic analog like TBG, produces sustained antidepressant-like effects through the growth of dendritic spines in the brain’s prefrontal cortex.
Following the biochemical flow
Using pharmacological and genetic tools in rodents, the team found that both TBG and 5-MeO-DMT promoted cortical neuroplasticity by activating the serotonin 2A receptor (5-HT2A). Both drugs then induced the downstream activation of the same receptors and proteins, including TrkB, mTOR and AMPA.
This means that that despite TBG being non-hallucinogenic, it turns on one of the same biochemical pathways that psychedelics do. Whereas 5-MeO-DMT is a full agonist, TBG is a partial agonist.
Olson likened agonists to water faucets. Full agonists turn on the faucet all the way, allowing for a full flow of water, while partial agonists only allow for drips and limited streams.
“Full agonists turn on hallucinations and they also turn on plasticity,” Olson said. “Partial agonists only turn on the receptor part way and that seems to be sufficient to turn on plasticity.”
Link between neuroplasticity and antidepressant effects
The study addressed an open question in psychedelic science. While the activation of 5-HT2A receptors by psychedelics is known to promote neuroplasticity, the link between this and psychedelics’ sustained antidepressant effects was unclear.
“Are the neuroplasticity-promoting effects — the growth of these dendritic spines in the prefrontal cortex — responsible for the antidepressant effects?” Olson wondered.
It turns out, they are.
With advanced genetic tools, the team tagged the dendritic spines that grew in the prefrontal cortex after TBG dosing. They then used lasers to erase those spines.
“When we erased those spines, the antidepressant effect went away,” Olson said.
Previously, this kind of experiment was conducted with ketamine to demonstrate that its sustained antidepressant-like properties required the growth of these dendritic spines.
“This is the first time that we’ve done this with a serotonergic agent,” Olson said. “And we find that cortical neuroplasticity is at least responsible for some of the compound’s antidepressant-like effects.”
Similarities and differences
While 5-MeO-DMT and TBG boasted similarities in their effects on neuroplasticity, there were critical differences. Unlike 5-MeO-DMT, TBG didn’t promote bursts of glutamate or turn on immediate early genes — genes long thought to be critical for the neuroplasticity-promoting effects of psychedelics.
“It was kind of shocking that TBG promoted plasticity, but the glutamate burst and immediate early genes were not required,” Olson said. The team used a combination of whole brain imaging and single-nucleus RNA sequencing to profile gene expression patterns following treatment with 5-MeO-DMT and TBG. “What we found is that glutamate bursts and immediate early gene expression are probably more related to the hallucinogenic properties of psychedelics rather than their plasticity-promoting effects.”
“Science is full of surprises,” said Gray. “There is still so much we don’t know about how psychedelics impact the brain, and it feels like we learn something new every day.”
Additional co-authors include Isak K. Aarrestad, Lindsay P. Cameron, Ethan M. Fenton, Austen B. Casey, Daniel R. Rijsketic, Seona D. Patel, Rohini Sambyal, Shane B. Johnson, Calvin Ly, Jayashri Viswanathan, Eden V. Barragan, Stephanie A. Lozano, Nicolas Seban, Hongru Hu, Noel A. Powell, Milan Chytil, Retsina Meyer, David Rose, Chris Hempel, Eric Olson, Hanne D. Hansen, Clara A. Madsen, Gitte M. Knudsen, Chase Redd, Damian G. Wheeler, Nathaniel Guanzon, Jessie Muir, Joseph J. Hennessey, Gerald Quon, John D. McCorvy, Sunil P. Gandhi, Kurt Rasmussen, Conor Liston, John A. Gray, Boris D. Heifets, Alex S. Nord and Christina K. Kim.
The research reported here was supported by grants from the National Institutes of Health, the Camille and Henry Dreyfus Foundation, a Hellman Fellowship, the Boone Family Foundation, the WoodNext Foundation and a sponsored research agreement with Delix Therapeutics. Olson is co-founder and chief innovation officer of Delix Therapeutics.
END
Psychedelics and non-hallucinogenic analogs work through the same receptor, up to a point
2025-08-04
ELSE PRESS RELEASES FROM THIS DATE:
The Lancet: Plastic pollution is an underrecognised threat to health, experts warn as they launch a project to track plastics’ health impacts and monitor progress
2025-08-03
The Lancet: Plastic pollution is an underrecognised threat to health, experts warn as they launch a project to track plastics’ health impacts and monitor progress
Ahead of the expected finalisation of an UN global plastics treaty [1], a group of international experts call for a greater focus on health impacts when considering plastic pollution. The Health Policy published in The Lancet reviews the current evidence on how plastics – including microplastics and plastic chemicals - impact health and announces the launch of a new project tracking ...
The Lancet Countdown on Health and Plastics to track impact of plastic production and pollution on human health
2025-08-03
Chestnut Hill, Mass. (8/4/2025) – With the latest round of negotiations to finalize a United Nations global plastics treaty set to begin, a group of international researchers, writing in the most recent edition of The Lancet, have called for greater vigilance and regulation to curb the health impacts of plastic pollution and have announced a new project to track these impacts.
An estimated 8 billion metric tons of plastic waste now pollute the planet. Across their lifecycle, plastics – including plastic chemicals - result in a range of adverse health outcomes, the researchers write in a Health Policy ...
Announcing The Lancet Countdown on Health and Plastics
2025-08-03
A new report published in The Lancet issues a fresh clarion call: plastic pollution is a grave and growing danger to human and planetary health. As Ministers and diplomats arrive in Geneva for the final round of talks to conclude a global plastics treaty, the report provides the most up-to-date assessment of the links between health and plastic pollution across the full life cycle of plastic.
An estimated 8 billion metric tons of plastic waste now pollute the planet. Micro- and nanoplastic particles and multiple plastic chemicals are found in ...
Study unexpectedly finds living in rural, rather than urban environments in first five years of life could be a risk factor for developing type 1 diabetes
2025-08-01
New research to be presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) suggests that living in a rural environment in the first five years of life could increase the risk of developing type 1 diabetes compared with living in urban environments. The study is by Samy Sebraoui and Professor Soffia Gudbjornsdottir, University of Gothenburg, Sweden, and colleagues.
Type 1 diabetes (T1D) is a chronic autoimmune disease where the body's immune system mistakenly attacks and destroys insulin-producing cells in the pancreas, called beta cells. This ...
Editorial urges deeper focus on heart-lung interactions in pulmonary vascular disease
2025-08-01
DENVER - A new editorial published in Comprehensive Physiology underscores the critical importance of understanding heart-lung interactions in pulmonary vascular disease (PVD). Tim Lahm, MD, a pulmonologist and researcher at National Jewish Health, along with a team of esteemed colleagues from institutions across the country, urges the scientific community to confront the major knowledge gaps that hinder progress in improving patient outcomes. The editorial, titled "Towards a Better Understanding of Heart-Lung Interactions in Pulmonary ...
Five University of Tennessee faculty receive Fulbright Awards
2025-08-01
Five faculty members at the University of Tennessee, Knoxville — Christopher Cherry, Virginia Corrigan, Bernard Issa, Hector Pulgar and Tong (Toni) Wang — have been selected to receive Fulbright U.S. Scholar Program awards for the 2025-26 academic year from the U.S. Department of State and the Fulbright Foreign Scholarship Board.
Fulbright U.S. Scholars are faculty, researchers, administrators and established professionals teaching or conducting research in affiliation with institutes abroad. Fulbright Scholars engage in ...
5 advances to protect water sources, availability
2025-08-01
Water is an essential requirement for life on Earth — it supports everything from cellular processes to ecosystems. Five papers published in ACS journals provide new insights to help protect natural water sources and ensure that more people have access to safe drinking water. Reporters can request free access to these papers by emailing newsroom@acs.org.
Reducing salt contamination of tidal rivers. Across the globe, the saltwater portion of tidal rivers — which rise and fall with the ocean tides — has been traveling farther upstream in the last few decades. Researchers publishing in Environmental ...
OU Scholar awarded Fulbright for Soviet cinema research
2025-08-01
University of Oklahoma Associate Professor Dustin Condren, Ph.D., has been named a 2025-2026 Fulbright U.S. Scholar by the U.S. Department of State and the Fulbright Foreign Scholarship Board.
Condren is among around 400 scholars selected nationwide for the prestigious international award. The Fulbright Scholars program aims to promote mutual understanding between the people of the U.S. and those from other nations. Candidates are chosen based on their academic achievements and the strength of their proposed project.
“We are immensely proud of Dr. Condren for being ...
Brain might become target of new type 1 diabetes treatments
2025-08-01
More than a decade ago, researchers found that an acute complication of type 1 diabetes, diabetic ketoacidosis (DKA), can be resolved with the hormone leptin, even in the absence of insulin.
An analysis published today in The Journal of Clinical Investigation explains how leptin affects the brain and how it might be used in future therapeutics.
DKA happens when the body is unable to make insulin and begins to break down fat for fuel. This can lead to a life-threatening buildup of sugar (glucose) and ketoacids in the blood. Doctors have typically administered insulin to address ...
‘Shore Wars:’ New research aims to resolve coastal conflict between oysters and mangroves, aiding restoration efforts
2025-08-01
Oysters and mangroves are both essential to protecting and restoring Florida’s coastlines that they call home, including defending them against storms.
As mangrove populations are increasing due to successful restoration efforts and favorable weather, however, their strong comeback may pose unintended consequences for oysters, according to new research from UCF graduate student Katherine Harris and Pegasus Professor Linda Walters published in the Marine Ecology Progress Series.
To protect Florida’s coastlines, the researchers hope their new findings can initiate efforts ...